Skip to main content
. 2019 Jul 1;15(3):183–190. doi: 10.5152/ejbh.2019.4761

Table 5.

Summary of cost-effectiveness results for the base case analysis

Usual care Oncotype DX testing Difference
Cost $3649.3 $8568.6 $4919.3
Life Expectancy (years) 24.84 LY 25.70 LY 0.86 LY
Quality-Adjusted-Life Expectancy (QALYs) 19.26 QALY 19.94 QALY 0.68 QALY
ICER (USD per life year gained) $5720.6 per LY gained
ICER (USD per QALY gained) $7207.9 per QALY gained

ICER: incremental cost-effectiveness ratio; QALYs: quality-adjusted life years; LYs: life years